预测COVID-19特定和非COVID-19特定死亡的预测因素:台湾的一个队列研究
Shang-Yih Chan1,2,3, Hsin-Hao Lai4,5, Yun-Ju Lai2,5,6,7
1Department of Cardiology, Taipei City Hospital-Heping Fuyou Branch, Taipei.
Asia-Pacific journal of public health
|September 23, 2024
概括
确定了住院COVID-19患者死亡的预测因素. 接种疫苗和Paxlovid减少了COVID-19的死亡,而老年和并发症增加了COVID-19和非COVID-19死亡的风险.
科学领域:
- * 传染病 传染病
- * 流行病学 流行病学
- * 老年医学是一门老年医学
背景情况:
- *了解严重急性呼吸综合征冠状病毒2 (SARS-CoV-2) 感染患者死亡率的预测因素至关重要.
- *区分2019年冠状病毒病 (COVID-19) 特定的和非COVID-19特定的死亡需要进一步调查.
研究的目的:
- * 确定住院SARS-CoV-2感染患者中COVID-19特定和非COVID-19特定死亡的预测因素.
- * 评估疫苗接种情况和抗病毒治疗对死亡率结果的影响.
主要方法:
- * 一项前性队列研究涉及2022年1月至7月在台湾住院的2196名COVID-19患者.
- *多项逻辑回归分析用于确定不同死亡原因的显著预测因素.
- *数据包括患者人口统计,疫苗接种情况,治疗和并发症.
主要成果:
- * 在175名已故患者中,84%死于COVID-19特定原因,16%死于非COVID-19特定原因.
- *年龄≥65显著增加了COVID-19特定 (AOR=6.21) 和非COVID-19特定死亡 (AOR=6.06) 的风险.
- *完全接种疫苗 (AOR=0.50) 和帕克斯洛维德治疗 (AOR=0.45) 与较低的COVID-19特异性死亡率有关,而癌症或末期脏疾病增加了非COVID-19特异性死亡风险.
结论:
- * 疫苗接种和Paxlovid在减少COVID-19特定死亡率方面是有效的.
- *老年人和患有特定并发症的患者需要密切监测,以减轻非COVID-19特定的死亡风险.
- *区分死亡原因对于住院COVID-19患者的有针对性的干预措施至关重要.
相关概念视频
Assumptions of Survival Analysis
104
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
104
Actuarial Approach
64
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
64
Comparing the Survival Analysis of Two or More Groups
158
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
158
Statistical Methods for Analyzing Epidemiological Data
316
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
316
Censoring Survival Data
69
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
69
Cancer Survival Analysis
331
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
331


